Detail
Article
Online article
FT
Medvik - BMC
  • Something wrong with this record ?

Caspase dependent apoptotic activity of Rubus fairholmianus Gard. on MCF-7 human breast cancer cell lines

Blassan P. George, Heidi Abrahamse, Thangaraj Parimelazhagan

. 2016 ; 14 (3) : 211-219.

Language English Country Czech Republic

Developing plant derived chemopreventive agents that can divert the carcinogenic process and inhibit tumour progression may greatly reduce serious health consequences of cancer. This study investigated the antiproliferative and apoptosis inducing ability of Rubus fairholmianus root acetone (RFRA) on MCF-7 cells. RFRA treatments showed an increase in the in vivo antioxidant levels such as superoxide dismutase (SOD), catalase (CAT), glutathione peroxidase (GPx) and glutathione (GSH) in mice. The extract showed significant antitumour activity with 76.57% increase in life span of ascites tumour bearing mice and 1.94 cm3 reductions in solid tumour volume at 250 mg/kg. The cytotoxicity spectrum analysis indicated that RFRA is a potent cytocidal agent with varying levels of toxicity (IC50: 57.14–29.36 μg/ml). A significant dose dependent decrease in viability, proliferation and increase in cytotoxicity, caspase 3/7 activity were observed in MCF-7 cells. RFRA (20 μg/ml) induced apoptosis in MCF-7 cells, which was observed by morphology; DNA ladder formation and increased apoptotic population in flow cytometry analysis. These findings strongly suggest the use of R. fairholmianus as natural antioxidant with profound antitumour activities. It can act as a potent cytotoxic agent, which is able to induce apoptosis in MCF-7 cells via caspase 3/7 upregulation.

References provided by Crossref.org

Bibliography, etc.

Literatura

000      
00000naa a2200000 a 4500
001      
bmc16030318
003      
CZ-PrNML
005      
20170206162540.0
007      
ta
008      
161025s2016 xr ad f 000 0|eng||
009      
AR
024    7_
$a 10.1016/j.jab.2016.02.001 $2 doi
040    __
$a ABA008 $d ABA008 $e AACR2 $b cze
041    0_
$a eng
044    __
$a xr
100    1_
$a George, Blassan P. $u Laser Research Centre, Faculty of Health Sciences, University of Johannesburg, P.O. Box 17011, Doornfontein 2028, South Africa
245    10
$a Caspase dependent apoptotic activity of Rubus fairholmianus Gard. on MCF-7 human breast cancer cell lines / $c Blassan P. George, Heidi Abrahamse, Thangaraj Parimelazhagan
504    __
$a Literatura
520    9_
$a Developing plant derived chemopreventive agents that can divert the carcinogenic process and inhibit tumour progression may greatly reduce serious health consequences of cancer. This study investigated the antiproliferative and apoptosis inducing ability of Rubus fairholmianus root acetone (RFRA) on MCF-7 cells. RFRA treatments showed an increase in the in vivo antioxidant levels such as superoxide dismutase (SOD), catalase (CAT), glutathione peroxidase (GPx) and glutathione (GSH) in mice. The extract showed significant antitumour activity with 76.57% increase in life span of ascites tumour bearing mice and 1.94 cm3 reductions in solid tumour volume at 250 mg/kg. The cytotoxicity spectrum analysis indicated that RFRA is a potent cytocidal agent with varying levels of toxicity (IC50: 57.14–29.36 μg/ml). A significant dose dependent decrease in viability, proliferation and increase in cytotoxicity, caspase 3/7 activity were observed in MCF-7 cells. RFRA (20 μg/ml) induced apoptosis in MCF-7 cells, which was observed by morphology; DNA ladder formation and increased apoptotic population in flow cytometry analysis. These findings strongly suggest the use of R. fairholmianus as natural antioxidant with profound antitumour activities. It can act as a potent cytotoxic agent, which is able to induce apoptosis in MCF-7 cells via caspase 3/7 upregulation.
650    _2
$a zvířata $7 D000818
650    _2
$a myši $7 D051379
650    12
$a Rubus $7 D065856
650    _2
$a kořeny rostlin $7 D018517
650    _2
$a rostlinné extrakty $x farmakologie $7 D010936
650    12
$a nádorové buněčné linie $x účinky léků $7 D045744
650    _2
$a MFC-7 buňky $x účinky léků $7 D061986
650    _2
$a viabilita buněk $x účinky léků $7 D002470
650    _2
$a proliferace buněk $x účinky léků $7 D049109
650    _2
$a buněčná smrt $x účinky léků $7 D016923
650    _2
$a antioxidancia $x farmakologie $7 D000975
650    _2
$a annexin A5 $7 D017304
650    _2
$a kaspasy $7 D020169
650    _2
$a apoptóza $7 D017209
650    _2
$a cytotoxiny $x farmakologie $7 D003603
650    12
$a protinádorové látky $x farmakologie $7 D000970
700    1_
$a Abrahamse, Heidi $u Laser Research Centre, Faculty of Health Sciences, University of Johannesburg, P.O. Box 17011, Doornfontein 2028, South Africa $7 gn_A_00000745
700    1_
$a Parimelazhagan, Thangaraj $u Bioprospecting Laboratory, Department of Botany, Bharathiar University, Coimbatore 641 046, Tamil Nadu, India
773    0_
$t Journal of applied biomedicine $x 1214-021X $g Roč. 14, č. 3 (2016), s. 211-219 $w MED00012667
856    41
$u https://jab.zsf.jcu.cz/pdfs/jab/2016/03/05.pdf $y plný text volně přístupný
910    __
$a ABA008 $b B 2301 $c 1249 $y 4 $z 0
990    __
$a 20150522215938 $b ABA008
991    __
$a 20170206162710 $b ABA008
999    __
$a ok $b bmc $g 1169490 $s 954958
BAS    __
$a 3
BMC    __
$a 2016 $b 14 $c 3 $d 211-219 $i 1214-021X $m Journal of Applied Biomedicine $x MED00012667
LZP    __
$c NLK188 $d 20170206 $a NLK 2016-36/dk

Find record

Citation metrics

Loading data ...

Archiving options

Loading data ...